Cardiovascular disease management during the coronavirus disease 2019 pandemic.
Identifieur interne : 001231 ( Main/Corpus ); précédent : 001230; suivant : 001232Cardiovascular disease management during the coronavirus disease 2019 pandemic.
Auteurs : Wen-Hsien Lee ; Ying-Chih Chen ; Szu-Chia Chen ; Chang-Jen Chen ; Po-Chao Hsu ; Wei-Chung Tsai ; Chun-Yuan Chu ; Chee-Siong Lee ; Tsung-Hsien Lin ; Wen-Chol Voon ; Chao-Hung Kuo ; Ho-Ming SuSource :
- International journal of medical sciences [ 1449-1907 ] ; 2020.
English descriptors
- KwdEn :
- MESH :
- complications : Coronavirus Infections, Pneumonia, Viral.
- therapy : Heart Diseases.
- virology : Heart Diseases.
- COVID-19, Cardiac Catheterization, Humans, Infection Control, Pandemics.
Abstract
Based on clinical presentation, pathophysiology, high infectivity, high cardiovascular involvement, and therapeutic agents with cardiovascular toxicity of coronavirus disease 2019 (COVID-19), regular cardiovascular treatment is being changing greatly. Despite angiotensin-converting enzyme 2 serving as the portal for infection, the continuation of clinically indicated renin-angiotensin-aldosterone blockers is recommended according to the present evidence. Fibrinolytic therapy can be considered a reasonable option for the relatively stable ST segment elevation myocardial infarction (STEMI) patient with suspected or known COVID-19. However, primary percutaneous coronary intervention is still the standard of care in patients with definite STEMI if personal protective equipment is available and cardiac catheterization laboratory has a good infection control. In patients with elevated cardiac enzymes, it is very important to differentiate patients with Type 2 myocardial infarction or myocarditis from those with true acute coronary syndromes because invasive percutaneous intervention management in the former may be unnecessary, especially if they are hemodynamically stable. Finally, patients with baseline QT prolongation or those taking QT prolonging drugs must be cautious when treating with lopinavir/ritonavir and hydroxychloroquine for COVID-19.
DOI: 10.7150/ijms.46484
PubMed: 32624690
PubMed Central: PMC7330658
Links to Exploration step
pubmed:32624690Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cardiovascular disease management during the coronavirus disease 2019 pandemic.</title><author><name sortKey="Lee, Wen Hsien" sort="Lee, Wen Hsien" uniqKey="Lee W" first="Wen-Hsien" last="Lee">Wen-Hsien Lee</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Ying Chih" sort="Chen, Ying Chih" uniqKey="Chen Y" first="Ying-Chih" last="Chen">Ying-Chih Chen</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Szu Chia" sort="Chen, Szu Chia" uniqKey="Chen S" first="Szu-Chia" last="Chen">Szu-Chia Chen</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Chang Jen" sort="Chen, Chang Jen" uniqKey="Chen C" first="Chang-Jen" last="Chen">Chang-Jen Chen</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Hsu, Po Chao" sort="Hsu, Po Chao" uniqKey="Hsu P" first="Po-Chao" last="Hsu">Po-Chao Hsu</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Tsai, Wei Chung" sort="Tsai, Wei Chung" uniqKey="Tsai W" first="Wei-Chung" last="Tsai">Wei-Chung Tsai</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Chu, Chun Yuan" sort="Chu, Chun Yuan" uniqKey="Chu C" first="Chun-Yuan" last="Chu">Chun-Yuan Chu</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Lee, Chee Siong" sort="Lee, Chee Siong" uniqKey="Lee C" first="Chee-Siong" last="Lee">Chee-Siong Lee</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Lin, Tsung Hsien" sort="Lin, Tsung Hsien" uniqKey="Lin T" first="Tsung-Hsien" last="Lin">Tsung-Hsien Lin</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Voon, Wen Chol" sort="Voon, Wen Chol" uniqKey="Voon W" first="Wen-Chol" last="Voon">Wen-Chol Voon</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Kuo, Chao Hung" sort="Kuo, Chao Hung" uniqKey="Kuo C" first="Chao-Hung" last="Kuo">Chao-Hung Kuo</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Su, Ho Ming" sort="Su, Ho Ming" uniqKey="Su H" first="Ho-Ming" last="Su">Ho-Ming Su</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32624690</idno><idno type="pmid">32624690</idno><idno type="doi">10.7150/ijms.46484</idno><idno type="pmc">PMC7330658</idno><idno type="wicri:Area/Main/Corpus">001231</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001231</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cardiovascular disease management during the coronavirus disease 2019 pandemic.</title><author><name sortKey="Lee, Wen Hsien" sort="Lee, Wen Hsien" uniqKey="Lee W" first="Wen-Hsien" last="Lee">Wen-Hsien Lee</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Ying Chih" sort="Chen, Ying Chih" uniqKey="Chen Y" first="Ying-Chih" last="Chen">Ying-Chih Chen</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Szu Chia" sort="Chen, Szu Chia" uniqKey="Chen S" first="Szu-Chia" last="Chen">Szu-Chia Chen</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Chang Jen" sort="Chen, Chang Jen" uniqKey="Chen C" first="Chang-Jen" last="Chen">Chang-Jen Chen</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Hsu, Po Chao" sort="Hsu, Po Chao" uniqKey="Hsu P" first="Po-Chao" last="Hsu">Po-Chao Hsu</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Tsai, Wei Chung" sort="Tsai, Wei Chung" uniqKey="Tsai W" first="Wei-Chung" last="Tsai">Wei-Chung Tsai</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Chu, Chun Yuan" sort="Chu, Chun Yuan" uniqKey="Chu C" first="Chun-Yuan" last="Chu">Chun-Yuan Chu</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Lee, Chee Siong" sort="Lee, Chee Siong" uniqKey="Lee C" first="Chee-Siong" last="Lee">Chee-Siong Lee</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Lin, Tsung Hsien" sort="Lin, Tsung Hsien" uniqKey="Lin T" first="Tsung-Hsien" last="Lin">Tsung-Hsien Lin</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Voon, Wen Chol" sort="Voon, Wen Chol" uniqKey="Voon W" first="Wen-Chol" last="Voon">Wen-Chol Voon</name><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Kuo, Chao Hung" sort="Kuo, Chao Hung" uniqKey="Kuo C" first="Chao-Hung" last="Kuo">Chao-Hung Kuo</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author><author><name sortKey="Su, Ho Ming" sort="Su, Ho Ming" uniqKey="Su H" first="Ho-Ming" last="Su">Ho-Ming Su</name><affiliation><nlm:affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation></affiliation></author></analytic><series><title level="j">International journal of medical sciences</title><idno type="eISSN">1449-1907</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>COVID-19 (MeSH)</term><term>Cardiac Catheterization (MeSH)</term><term>Coronavirus Infections (complications)</term><term>Heart Diseases (therapy)</term><term>Heart Diseases (virology)</term><term>Humans (MeSH)</term><term>Infection Control (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Heart Diseases</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Heart Diseases</term></keywords><keywords scheme="MESH" xml:lang="en"><term>COVID-19</term><term>Cardiac Catheterization</term><term>Humans</term><term>Infection Control</term><term>Pandemics</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Based on clinical presentation, pathophysiology, high infectivity, high cardiovascular involvement, and therapeutic agents with cardiovascular toxicity of coronavirus disease 2019 (COVID-19), regular cardiovascular treatment is being changing greatly. Despite angiotensin-converting enzyme 2 serving as the portal for infection, the continuation of clinically indicated renin-angiotensin-aldosterone blockers is recommended according to the present evidence. Fibrinolytic therapy can be considered a reasonable option for the relatively stable ST segment elevation myocardial infarction (STEMI) patient with suspected or known COVID-19. However, primary percutaneous coronary intervention is still the standard of care in patients with definite STEMI if personal protective equipment is available and cardiac catheterization laboratory has a good infection control. In patients with elevated cardiac enzymes, it is very important to differentiate patients with Type 2 myocardial infarction or myocarditis from those with true acute coronary syndromes because invasive percutaneous intervention management in the former may be unnecessary, especially if they are hemodynamically stable. Finally, patients with baseline QT prolongation or those taking QT prolonging drugs must be cautious when treating with lopinavir/ritonavir and hydroxychloroquine for COVID-19.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32624690</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1449-1907</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>10</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>International journal of medical sciences</Title><ISOAbbreviation>Int J Med Sci</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular disease management during the coronavirus disease 2019 pandemic.</ArticleTitle><Pagination><MedlinePgn>1340-1344</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7150/ijms.46484</ELocationID><Abstract><AbstractText>Based on clinical presentation, pathophysiology, high infectivity, high cardiovascular involvement, and therapeutic agents with cardiovascular toxicity of coronavirus disease 2019 (COVID-19), regular cardiovascular treatment is being changing greatly. Despite angiotensin-converting enzyme 2 serving as the portal for infection, the continuation of clinically indicated renin-angiotensin-aldosterone blockers is recommended according to the present evidence. Fibrinolytic therapy can be considered a reasonable option for the relatively stable ST segment elevation myocardial infarction (STEMI) patient with suspected or known COVID-19. However, primary percutaneous coronary intervention is still the standard of care in patients with definite STEMI if personal protective equipment is available and cardiac catheterization laboratory has a good infection control. In patients with elevated cardiac enzymes, it is very important to differentiate patients with Type 2 myocardial infarction or myocarditis from those with true acute coronary syndromes because invasive percutaneous intervention management in the former may be unnecessary, especially if they are hemodynamically stable. Finally, patients with baseline QT prolongation or those taking QT prolonging drugs must be cautious when treating with lopinavir/ritonavir and hydroxychloroquine for COVID-19.</AbstractText><CopyrightInformation>© The author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Wen-Hsien</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ying-Chih</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Szu-Chia</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chang-Jen</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Po-Chao</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Wei-Chung</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Chun-Yuan</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chee-Siong</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Tsung-Hsien</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voon</LastName><ForeName>Wen-Chol</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Chao-Hung</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Ho-Ming</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Int J Med Sci</MedlineTA><NlmUniqueID>101213954</NlmUniqueID><ISSNLinking>1449-1907</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006328" MajorTopicYN="N">Cardiac Catheterization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiovascular</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword></KeywordList><CoiStatement>Competing Interests: The authors have declared that no competing interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>03</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32624690</ArticleId><ArticleId IdType="doi">10.7150/ijms.46484</ArticleId><ArticleId IdType="pii">ijmsv17p1340</ArticleId><ArticleId IdType="pmc">PMC7330658</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):219-222</Citation><ArticleIdList><ArticleId IdType="pubmed">32164092</ArticleId></ArticleIdList></Reference><Reference><Citation>Catheter Cardiovasc Interv. 2020 Apr 20;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32311816</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Res Cardiol. 2020 May;109(5):531-538</Citation><ArticleIdList><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovasc Toxicol. 2015 Jul;15(3):232-40</Citation><ArticleIdList><ArticleId IdType="pubmed">25367413</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Mar 20;:105949</Citation><ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 2004 Mar;59(3):252-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14985565</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Heart Fail. 2020 May 15;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32412156</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Feb 7;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2020 May 12;75(18):2372-2375</Citation><ArticleIdList><ArticleId IdType="pubmed">32199938</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation><ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Ther. 2020 May 6;14(2):105-106</Citation><ArticleIdList><ArticleId IdType="pubmed">32213760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2020 Apr;8(4):e21</Citation><ArticleIdList><ArticleId IdType="pubmed">32171062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation><ArticleIdList><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin Med J (Engl). 2020 May 5;133(9):1025-1031</Citation><ArticleIdList><ArticleId IdType="pubmed">32044814</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2020 May 14;26(8):</Citation><ArticleIdList><ArticleId IdType="pubmed">32407284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation><ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140</Citation><ArticleIdList><ArticleId IdType="pubmed">23256914</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Physiol Heart Circ Physiol. 2020 May 1;318(5):H1084-H1090</Citation><ArticleIdList><ArticleId IdType="pubmed">32228252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertension. 2020 Jun;75(6):1382-1385</Citation><ArticleIdList><ArticleId IdType="pubmed">32208987</ArticleId></ArticleIdList></Reference><Reference><Citation>Catheter Cardiovasc Interv. 2020 Apr 22;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32320138</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Pharmacol Sci. 2004 Jun;25(6):291-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15165741</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2020 Jun;46(6):1111-1113</Citation><ArticleIdList><ArticleId IdType="pubmed">32162032</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cardiol. 2020 May;17(5):259-260</Citation><ArticleIdList><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001231 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001231 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32624690
|texte= Cardiovascular disease management during the coronavirus disease 2019 pandemic.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32624690" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |